You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Multidrug Resistant (MDR) Pseudomonas

Showing 1 - 25 of 5,779
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Household Transmission Dynamics of Multidrug Resistant

Not yet recruiting
  • Adults Patients, With Fecal Carriage of Multi-Drug Resistant Enterobacterales (MDR-E)
    • (no location specified)
    Apr 3, 2023

    Tuberculosis, Multidrug Resistant Trial in Chernivtsi, Ivano-Frankivs'k, Kharkiv (RUTI® Therapeutic vaccine, Matching RUTI®

    Terminated
    • Tuberculosis, Multidrug Resistant
    • RUTI® Therapeutic vaccine
    • Matching RUTI® Placebo
    • Chernivtsi, Ukraine
    • +2 more
    Jun 30, 2022

    Tuberculosis, HIV Trial in Haiti, India, South Africa (Bedaquiline)

    Recruiting
    • Tuberculosis
    • HIV Infections
    • Port-au-Prince, Haiti
    • +4 more
    Jun 15, 2022

    Tuberculosis, Multidrug-Resistant Trial (Amikacin)

    Not yet recruiting
    • Tuberculosis, Multidrug-Resistant
    • (no location specified)
    Sep 23, 2022

    Tuberculosis, Multidrug-Resistant Trial in Dasmariñas, Hanoi (Delamanid, Levofloxacin, Bedaquiline)

    Recruiting
    • Tuberculosis, Multidrug-Resistant
    • Dasmariñas, Philippines
    • +1 more
    Jun 21, 2022

    Bone Resistant Tuberculosis

    Completed
    • Bone and Osteoarticular Infection Due to MDR M. Tuberculosis Strains
    • Descriptive retrospective study
    • Paris, France
      Pitié Salpêtrière Hospital
    May 9, 2022

    ICU-acquired Colonization and Infection Related to MDR in

    Completed
    • Immunocompromised Host
    • Critical Care
      • Amiens, France
      • +6 more
      Oct 4, 2022

      Multidrug Resistant Bacterial Infection, Enterobacteriaceae Infections, Pseudomonas Aeruginosa Trial in Philadelphia (PMT)

      Not yet recruiting
      • Multidrug Resistant Bacterial Infection
      • +4 more
      • Philadelphia, Pennsylvania
        Hospital of the University of Pennsylvania
      Nov 17, 2022

      MDR-TB, Immunotherapy Trial in Shanghai (V?2Vd2 T lymphocyte-based immunotherapy, Treatment regimens for MDR-TB)

      Recruiting
      • MDR-TB
      • Immunotherapy
      • Vγ2Vδ2 T lymphocyte-based immunotherapy
      • Treatment regimens for MDR-TB
      • Shanghai, China
      • +1 more
      Aug 8, 2022

      Tuberculosis, Multidrug-Resistant, Infection, Bacterial, Pulmonary Tuberculoses Trial in Worldwide (Bedaquiline, Delamanid,

      Active, not recruiting
      • Tuberculosis, Multidrug-Resistant
      • +2 more
      • Tbilisi, Georgia
      • +11 more
      Feb 14, 2022

      MDR-TB Trial in Worldwide (Regimen A locally-used WHO-approved MDR-TB regimen (2011 guideline), Moxifloxacin, Clofazimine)

      Active, not recruiting
      • MDR-TB
      • Regimen A locally-used WHO-approved MDR-TB regimen (2011 guideline)
      • +9 more
      • Addis Ababa, Ethiopia
      • +12 more
      Oct 12, 2022

      Tuberculosis, Multidrug-Resistant, Tuberculosis, Pulmonary Tuberculoses Trial in Worldwide (Bedaquiline 100 MG, Delamanid 50 MG

      Recruiting
      • Tuberculosis, Multidrug-Resistant
      • +5 more
      • Bedaquiline 100 MG
      • +4 more
      • Pune, India
      • +9 more
      Mar 2, 2022

      Multi-drug Resistant Tuberculosis Trial in China (18-month regimen containing 6 anti-TB drugs)

      Completed
      • Multi-drug Resistant Tuberculosis
      • 18-month regimen containing 6 anti-TB drugs
      • Beijing, China
      • +19 more
      Oct 10, 2022

      Carbapenem-Resistant Enterobacteriaceae Infection, Bloodstream Infection, Severe Infection Trial in Brazil (Duration of therapy)

      Recruiting
      • Carbapenem-Resistant Enterobacteriaceae Infection
      • +9 more
      • Duration of therapy
      • Feira De Santana, Bahia, Brazil
      • +18 more
      Jan 27, 2022

      MDR-TB Trial in Shanghai (PRS Regimen V, MDR-TB Treatment Regimen(WHO))

      Recruiting
      • MDR-TB
      • PRS Regimen V
      • MDR-TB Treatment Regimen(WHO)
      • Shanghai, China
        Shanghai Pulmonary Hospital
      Aug 4, 2022

      Tuberculosis Trial in Cairo, Riyadh (13 cis retinoic acid, Minocycline, Chicroic Acid and Vitamin D for (MDR-TB), 9 cis retinoic

      Not yet recruiting
      • Tuberculosis
      • 13 cis retinoic acid, Minocycline, Chicroic Acid and Vitamin D for (MDR-TB)
      • +5 more
      • Cairo, Kafr El-sheikh, Egypt
      • +1 more
      Oct 11, 2021

      Tuberculosis Trial in Ogre, Siauliai, Vilnius (Delamanid, Optimized Background Regimen (OBR))

      Terminated
      Has Results
      • Tuberculosis
      • Ogre, Latvia
      • +2 more
      Oct 14, 2021

      Tuberculosis, Thoracic Surgery, Tuberculosis, Pulmonary Trial in Tbilisi (therapeutical surgery for TB)

      Active, not recruiting
      • Tuberculosis
      • +3 more
      • therapeutical surgery for TB
      • Tbilisi, Georgia
        National Center for Tuberculosis and Lung Diseases
      Sep 9, 2022

      Tuberculosis, MDR Trial in Kazakhstan, Kyrgyzstan (FS-1, Placebo)

      Completed
      • Tuberculosis, MDR
      • Semey, East-Kazakhstan Region, Kazakhstan
      • +5 more
      May 17, 2022

      Tuberculosis, MDR Trial in Worldwide (Delamanid (DLM), Isoniazid (INH), Pyridoxine (vitamin B6))

      Recruiting
      • Tuberculosis, MDR
      • Delamanid (DLM)
      • +2 more
      • Gaborone, South-East District, Botswana
      • +26 more
      Sep 22, 2022

      Expand New Drugs for TB [endTB]

      Completed
      • Tuberculosis, Multidrug-Resistant
      • This is a non-intervention observational study
      • Abovyan, Armenia
      • +15 more
      Jun 9, 2022

      CARRIER STATE Trial in Barcelona (PROBIOTIC, FMT REGIMEN)

      Recruiting
      • CARRIER STATE
      • PROBIOTIC
      • FMT REGIMEN
      • Barcelona, Spain
        Hospital Clinic
      Feb 11, 2021

      Multi-drug Resistant Tuberculosis Trial in Lambarene (Km+ Mfx+ Pto + H + Cfz +E+Z)

      Recruiting
      • Multi-drug Resistant Tuberculosis
      • Km+ Mfx+ Pto + H + Cfz +E+Z
      • Lambarene, Please Select, Gabon
        Centre de Recherches Médicales de Lambaréné
      Jul 26, 2021

      Pharmacometric Optimization of Second Line Drugs for MDR

      Completed
      • Multidrug-resistant Tuberculosis
        • Cape Town, Western Cape, South Africa
        • +1 more
        Apr 28, 2021

        Tuberculosis, Pulmonary, Tuberculosis, Multidrug-Resistant, Tuberculosis, MDR Trial in Worldwide (Pretomanid, Linezolid,

        Active, not recruiting
        • Tuberculosis, Pulmonary
        • +5 more
        • Tbilisi, Georgia
        • +10 more
        Jan 26, 2022